Form 4 for NGNE Neurogene Inc.

Accepted 2021-08-26 00:00:00 ET · period of report 2021-08-24 · accession 0001209191-21-053544 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2021-08-26	2021-08-25	NGNE	DRACHMAN JONATHAN G	Pres, CEO, Dir	P - Purchase	$6.45	+50.0K	25.0K	New	+$322.5K
	2021-08-26	2021-08-24	NGNE	DRACHMAN JONATHAN G	Pres, CEO, Dir	P - Purchase	$6.11	+100.0K	2.35M	+4%	+$611.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-08-25	P	A	25,000	$6.45	25,000	I	—	—	(F2) Represents the weighted average purchase price. The lowest price at which shares were purchased was $6.09 and the highest price at which shares were purchased was $6.60.
2	Common	Common Stock	2021-08-24	P	A	100,000	$6.11	2,348,686	D See footnote	—	—	(F1) Represents the weighted average purchase price. The lowest price at which shares were purchased was $6.1099 and the highest price at which shares were purchased was $6.1482. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. (F3) These securities are held by a spousal limited access trust of which the Reporting Person is the primary beneficiary.
3	Common	Common Stock	2021-08-25	P	A	25,000	$6.45	25,000	I See footnote	—	—	(F2) Represents the weighted average purchase price. The lowest price at which shares were purchased was $6.09 and the highest price at which shares were purchased was $6.60. (F4) These securities are held by a spousal limited access trust of which the Reporting Person's spouse is the primary beneficiary.